Sera Prognostics, Inc.SERA
Price as of · delayed, not real-time
A diagnostics company focused on women's health, developing blood-based tests to predict preterm birth and other pregnancy complications. Its lead product, the Sera Prognostics PreTRM test, is designed to provide early risk assessment, and the company is working to commercialize it through partnerships and clinical validation. Investors track Sera Prognostics for its potential to address a significant unmet need in prenatal care and for the commercial progress of its proprietary biomarker platform.
Congressional Interest in Sera Prognostics, Inc. (SERA)
No congressional trades have been disclosed for Sera Prognostics, Inc. (SERA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading SERA?
No congressional trades found for this stock.